Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,231 | 435 | 99.2% |
| Education | $48.05 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,044 | 92 | $0 (2024) |
| Amgen Inc. | $584.96 | 39 | $0 (2024) |
| Lilly USA, LLC | $541.16 | 36 | $0 (2024) |
| PFIZER INC. | $445.31 | 34 | $0 (2024) |
| ABBVIE INC. | $406.44 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $352.38 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $327.91 | 19 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $286.49 | 19 | $0 (2023) |
| Daiichi Sankyo Inc. | $252.31 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $192.16 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,518 | 95 | Amgen Inc. ($193.81) |
| 2023 | $1,113 | 76 | Novo Nordisk Inc ($231.35) |
| 2022 | $126.57 | 9 | Daiichi Sankyo Inc. ($46.50) |
| 2021 | $323.11 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($92.23) |
| 2020 | $618.23 | 49 | Novo Nordisk Inc ($153.34) |
| 2019 | $1,245 | 95 | Novo Nordisk Inc ($177.95) |
| 2018 | $607.33 | 46 | Novo Nordisk Inc ($120.64) |
| 2017 | $727.26 | 45 | Novo Nordisk Inc ($177.52) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.52 | General |
| 12/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.07 | General |
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.10 | General |
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Biological | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Obesity | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.83 | General |
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $46.12 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 529 | 832 | $151,056 | $43,488 |
| 2022 | 9 | 520 | 825 | $107,588 | $37,502 |
| 2021 | 10 | 643 | 1,046 | $126,615 | $72,305 |
| 2020 | 14 | 722 | 1,035 | $130,154 | $65,897 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 334 | $76,853 | $18,486 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 253 | $50,600 | $11,911 | 23.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,760 | $4,390 | 92.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 41 | $3,321 | $2,936 | 88.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $6,332 | $1,839 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 48 | $3,384 | $1,578 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,766 | $1,241 | 33.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $1,128 | $525.92 | 46.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 68 | $340.00 | $328.30 | 96.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $571.56 | $253.80 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 275 | $52,073 | $16,282 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 291 | $41,136 | $14,386 | 35.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $2,526 | $2,056 | 81.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $4,065 | $1,454 | 35.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 43 | $2,867 | $1,399 | 48.8% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 12 | 12 | $900.00 | $750.66 | 83.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,985 | $633.13 | 21.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 72 | 133 | $665.00 | $387.87 | 58.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $370.96 | $153.35 | 41.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 186 | 364 | $64,428 | $36,635 | 56.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 204 | 383 | $46,343 | $25,266 | 54.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 51 | 52 | $3,813 | $3,383 | 88.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 18 | $4,824 | $3,258 | 67.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 64 | 66 | $3,102 | $1,243 | 40.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 12 | $1,452 | $918.92 | 63.3% |
About Dr. Marlene Rodriguez, MD
Dr. Marlene Rodriguez, MD is a Family Medicine healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093822090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marlene Rodriguez, MD has received a total of $6,279 in payments from pharmaceutical and medical device companies, with $1,518 received in 2024. These payments were reported across 436 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,231).
As a Medicare-enrolled provider, Rodriguez has provided services to 2,414 Medicare beneficiaries, totaling 3,738 services with total Medicare billing of $219,192. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Northfield, NJ
- Active Since 08/24/2006
- Last Updated 02/02/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1093822090
Products in Payments
- JARDIANCE (Drug) $423.49
- Ozempic (Drug) $341.11
- VRAYLAR (Drug) $302.33
- INJECTAFER (Drug) $252.31
- Otezla (Drug) $216.83
- Kerendia (Drug) $192.16
- TRULICITY (Drug) $190.63
- Victoza (Drug) $188.13
- XARELTO (Drug) $139.58
- XIFAXAN (Drug) $134.59
- Korlym (Drug) $131.62
- Enbrel (Biological) $124.75
- Wegovy (Drug) $120.86
- Tresiba (Drug) $110.42
- Prolia (Biological) $108.62
- SOLIQUA 100/33 (Drug) $108.29
- AIRSUPRA (Drug) $107.06
- UBRELVY (Drug) $106.85
- CHANTIX (Drug) $95.61
- PREVNAR 20 (Biological) $93.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Northfield
Arthur Nahas, D.o, D.O
Family Medicine — Payments: $16,460
Dr. Seblewongel Bulcha Debosse, Md, MD
Family Medicine — Payments: $5,208
Dr. Stephen Bushay, Md, MD
Family Medicine — Payments: $2,639
Angel Reyes-Diaz, Md, MD
Family Medicine — Payments: $1,612
Gary Oxenberg, Md, MD
Family Medicine — Payments: $910.62
Dr. Donald Lum, Md, MD
Family Medicine — Payments: $130.00